Ajanta Pharma Ltd.

NSE: AJANTPHARM | BSE: 532331 | ISIN: INE031B01049 | Industry: Pharmaceuticals
| Mid-range Performer
2591.3000 -35.90 (-1.37%)
NSE Jul 10, 2025 15:31 PM
Volume: 256.8K
 

logo
Ajanta Pharma Ltd.
30 Jul 2021
2591.30
-1.37%
Motilal Oswal
Ajanta Pharma (AJP) delivered 1QFY22 earnings marginally below our expectation. Robust growth in Domestic Formulation (DF) / Branded Generics (Africa) was offset by moderate growth in US / Branded Generics (Asia) and enhanced opex towards marketing and promotional activities. AJP is on track to outperform in the Branded Generics segment across DF/Asia/Africa and build a product pipeline for the US market. We tweak our estimates for FY22E/FY23E, factoring in a) a better outlook for the Pain Management, Opthal, and Derma therapies in the DF segment,...
Ajanta Pharma Ltd. is trading above its 50 day SMA of 2582.0
More from Ajanta Pharma Ltd.
Recommended